Meetings from 1992 onwards

    2018 2017 2016 2015 2014 2013 2012 2011
2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
2000 1999   1997   1995 1994 1993 1992  






Symposium and business meeting: EAHP, Edinburgh, 29 September – 4 October 2018

"ALL and reactive lesions, T-NHL and Hodgkin Lymphoma, Aggressive B-NHL"




13th EBMWG International Course and Workshop on Bone Marrow Pathology.
Utrecht 27-30 May 2017

Organisers: Roos Leguit & Konnie Hebeda

TOPIC I: WHO Classification 2016 - Revisions and additions

TOPIC II: New techniques. Advances in diagnosis and therapeutic relevance

WORKSHOP: 1. Reactive cytopenia and dysplasia. 2. CHIP, ICUS and IDUS. 3. Overt MDS

Pre-meeting Course: “Bone Marrow Pathology for Beginners”


Scientific and Business Meeting. Athens September or October 2017

Organisers: Professor E Patsouris, Professor P Korkolopoulou and Maria Ioannoy




Symposium and business meeting: EAHP Basel.  3-8 September

“Aggressive Malignancies of the 'Other Cells' of the bone marrow: Histiocytes, Dendritic Cells and Mast Cells".




Scientific and business Meeting: Frankfurt.  September 24-26th

Organiser: Hans-Michael Kvasnicka



12th Course. Milano. 16-19 April

Local organizers:  Emanuela Boveri, Umberto Gianelli, Maurilio Ponzoni


“Myeloproliferative and myelodysplastic/myeloproliferative disorders: diagnostic issues.

New entities among acute myeloid leukaemias and myelodysplastic syndromes.

Mimics of myeloid neoplasms.

Myeloid neoplasms: post-therapy marrows.”




Symposium and business meeting: EAHP Istanbul.  17-22 October.

“Small B-cell lymphoid neoplasms in bone marrow: diagnostic advances.”

Workshop: Diagnostic difficulties in CLL, Bone marrow manifestations of LPL, MZL,SRPL, HCL-v and HCL, Small B-cell lymphomas in bone marrow multiclonality and composite lymphomas


26th ECP, London, 30 August – 3 September

Organiser: Jon van der Walt

2 sessions, a short course: “Haematopathology: Myeloproliferative Syndromes/MDS and Myeloproliferative Neoplasms: Mimics, progressions and transformation” and a Joint Short Course - Infectious Diseases Pathology / European Bone Marrow Working Group: “Infectious diseases involve the bone marrow”.




11th Course. Munich. 7-10 September

Local organizers:  Marcus Kremer, Hans-Peter Horny, Claus Hann von Weyhern


“Bone marrow failure and progression of myeloproliferative and myeloproliferative/myelodysplastic neoplasms.

Workshop: Challenging cases of congenital cytopaenias, Myelodysplasia including acute progression and acute progression of myeloproliferative and myeloproliferative/myelodysplastic neoplasms.”


Scientific and business Meeting: Warsaw, 17-18 May

Organiser: Bogna Ziarkiewicz-Wróblewska




Symposium and business meeting: EAHP Lisbon.  20-25 October.


“Reactive and neoplastic T-cell proliferations in the bone marrow.

Workshop: Aggressive mature T/NK cell lymphomas, T-cell prolymphocytic leukaemia and other T-cell proliferations and Bone Marrow Failure.”


Slide Seminar during the ESP meeting in Prague. 8-12 September

Organiser: Anna Porwit

 “Lymphomas involving Bone Marrow and Spleen”




10th Course. London. 13-15 April

Local organizer: Jon van der Walt


“Beyond WHO 2008. Grey Zones and Technical Innovations in Bone Marrow Diagnosis.  Workshop: “Cases from the grey zones of the WHO classification: Proving the rule?”


Slide Seminar during ESP meeting in Helsinki.  27 August – 1 September

Organiser: Anna Porwit


“State of the Art in the Diagnosis of frequent Neoplasms in the Bone Marrow”


Scientific and business meeting: Berlin 7-9 October

Organiser: Ioannis Anagnostopoulos




Symposium and business meeting: EAHP Uppsala. 25-30 September


“From molecular and histopathological bone marrow studies to therapy. Plasma cell myeloma and other plasma cell neoplasms - exciting new facts about an old disease. Blasts in the bone marrow:  Myeloproliferative neoplasms. Recent advances in pathogenesis. Myelodysplastic syndrome: from bone marrow studies to new therapies.  Impact of new prognostic markers on treatment decisions in acute myeloid leukaemia

Workshop: Unusual acute leukemias, Transformation of MPN and MDS, Myelosarcomas and other cases.”





9th Course. Geneva. 7-9 May

Local organizers: Bettina Borisch, Stephan Dirnhofer, Phillip Went


“General aspects of bone marrow pathology in the light of the new WHO classification, MDS/MPN/Acute Leukaemia, Reactive lympho-plasmacellular infiltrates with special emphasis on gene related changes”


Scientific and business Meeting: Szeged. 25-26 September

Organisers: Eniko. Bagdi and Laszlo. Krenac




Symposium and business meeting: EAHP Bordeaux. 20-25 September


“New WHO classification of myeloid neoplasms.  Interactions between stroma and haematopoiesis in the bone marrow (niche, angiogenesis, fibrosis).  MDS 5q-.  Workshop: MDS and reactive mimickers of neoplasm”




8th Course. Graz. 16 – 19 May

Local Organsiser: Christine Beham-Schmid, Peter Regitnig, Ariane Aigelsreiter, Karin Lichtenegger


“For beginners:

Evaluation of bone marrow biopsy. Normal bone marrow from birth to old age. Infectious disorders and effects of chemo/radiotherapy. Non-neoplastic haematological disorders (ITP, Perniciosa, polyglobulia).  Acute leukaemias. Reactive states mimicking AML and MDS. Mast cell and histiocytic disorders.

Main program:

WHO classification. MDS. Genetic predisposition to therapy related MDS and AML. Flow diagnostics of AML. CMMoL. Acute Panmyelosis. Treatment effects in MPN. Methods of JAK2 detection. Gene expression profiles in lymphoma subtyping. Viral infections in the BM. Post transplant biopsies. Infiltration patterns of lymphoma in the BM. Lymphoma with secretory capacity. Multiple myeloma and rare variants. Hodgkin’s lymphoma in the BM. T-cell leukaemias. Reactive and neoplastic B-cell infiltrates. Bone disorders. Metastasis.”


Scientific and business meeting: Athens. 6 October.

Organiser: Demi Anagnostou


Bone Marrow Pathology Short Course during ESP meeting in Istanbul. 8-13 September

Organiser: Jon van der Walt





Bone marrow symposium: EAHP. Vienna 7-12 October


“Chronic myeloproliferative diseases: new developments

Acute myeloid leukaemia: the impact of bone marrow histology

Workshop: AML and MDS, CMPD, malignant lymphoma”


Scientific and business meeting: London 24-26 June

Organiser: Kristin Henry




7th Course. Krakow.  18-21 May

Local organiser: Zbigniew Rudzki


“Reactive states, therapy associated changes, acute leukaemias, myelodysplastic and myeloproliferative syndromes, lymphoproliferative disorders (patterns, pitfalls, plasma cell differentiation, molecular clonality analysis) and paediatric bone marrows (MDS, lymphoblastic leukemia, non-haematopoietic tumours). Early stages of MPN. Chronic anaemias including aplastic anaemia. Bone diseases.”


First Bone Marrow Pathology Short Course during ESP meeting in Paris. 3-7 September

Organiser: Jon van der Walt


Business meeting: Paris. 21-22 November

Organiser: Martine Raphael




First symposium and business meeting jointly with EAHP. Thessaloniki. 26 September – 1 October

Local organizer: Vasiliki Kaloutsi


“B-NHL involving primarily the bone marrow (including one lecture from Stein on “B-cell neoplasms with prominent plasma cell differentiation: overlaps and distinction”.  T-NHL and T-cell dysfunction with primary manifestation in bone marrow and spleen.  Recent advances in bone marrow diagnostics

Workshop subjects were related to the first two main subjects”


Business meeting: Stockholm. 17- 19 June.

Organiser: Anna Porwit




6th Course and business meeting. Hannover. 9-11 May

Local organizer: Hans Kreipe

“CMPD, hypoplastic states and MDS, lymphoma with primary involvement of bone marrow and the spleen, reactive and therapy related changes, molecular and cytogenetic analysis of bone marrow trephines.”


Business meeting:  Bologna. 20-22 November

Organiser: Stephano Pileri




First Bone Marrow Symposium during EAHP Sienna. 29-30 May.

Local organizer: Leonardo Leoncini

Organisers: Nina Hurwitz and Stefano Pilleri


Business meeting: Basel. June

Organiser: Nina Hurwitz, Stephan Dirnhofer




5th Course and business meeting. Palermo. 3-6 November

Local organizer: G Campesi, A M Florena, V Franco, E Maresi, E Orlando, L Russo, C Tripodo


“5th international Course on Bone Marrow Pathology”. Bone Marrow Biopsy: Processing and evaluation.Myrlodysplasia .Lymphoproliferative disorders. Myeloproliferative disorders. Challenging differential diagnosis; Disclosing new features; Iatrogenic and Post-transplant bone marrow changes



Business meeting Utrecht. May

Organiser: Jan van den Tweel




Business meeting: Wurzburg

Organiser: Konrad Muller-Hermerlink




4th Course and business meeting. Athens. 19-23 May 1999

Local organizer: Demi Anagnostou


“Retrospective survey of development and application of bone marrow biopsies.  Mechanisms of normal and dysregulated haematopoiesis.  Update on methods for processing bone marrow biopsies. The art of bone marrow diagnosis.  Application and Interpretation of immunohistochemistry on bone marrow biopsies.  Clinical aspects of multiple myeloma.  Plasma cell Dyscrasias on bone marrow biopsies.  Bone and marrow changes under biphosphonates in benign and malignant disorders.  Histiocytic disorders on bone marrow biopsies.  Clinical aspects in MDS as reflexion of defective or dysregulated haematopoiesis.  Myelodysplastic features on bone marrow biopsy: benign and malignant conditions.  Diagnosis and prognosis of myelodysplastic syndromes.  Apoptosis on bone marrow biopsies in MDS.  Histological classification and staging of CMPDs correlated to cytogenetic findings.  Atypical bone marrow biopsy findings in CMPDs and MDS.  Pediatric MDS.”




3rd Course and business meeting. London.  21 May 1997

Local organiser: Kristin Henry


Cellular constituents and kinetics of Bone; Paediatric problems; Lympfoproliferative disorders; Iatrogenic bone marrow problems


Business meeting: Megakaryocytic disorders




2nd Course and business meeting. Basel. 15-18 November

Local organizer: Nina Hurwitz


The bone marrow: from patient to report.  Taking a biopsy.  Immunohistochemistry.  Reporting the bone marrow.  The classification and clinical aspects of MDS.  The bone marrow biopsy and bone marrow smear in MDS.  Myelodysplastic syndromes not included in the FAB-classification.  Differential diagnosis of the hypoplastic bone marrow.  Iatrogenic MDS and reactive dyshaematopoiesis.  Round table discussion on MDS.  Update in childhood preleukaemic disorders.  Histopathology of CML and its differential diagnosis.  Polycythemia vera and thrombocytopenia.  Myelofibrosis.  Myelodysplastic syndromes versus chronic myeloproliferative diseases.  AML and its differential diagnosis.  Bone marrow changes post chemotherapy and/or post transplantation.  Round table discussion on MPD.  New trends in hematopoietic precursor cell transplants.  The pathology of plasma cell dyscrasia.  Bone marrow involvement in large cells lymphomas.  Bone marrow involvement by Hodgkin's disease and its differential diagnosis.  Non-neoplastic infiltrates in the bone marrow.  Bone diseases in core biopsies of the bone marrow.  Round table discussion on lymphoproliferative disorders.




1st Course and business meeting. Utrecht.  11-14 may

Organiser: Jan van den Tweel


”Bone marrow development and interpretation.  Technical aspects of bone marrow investigation.  Bone marrow stroma; its role in haematopoiesis.  Clinicopathological features of myelodysplastic syndromes.  Histological characteristics of MDS.  MDS-like diseases, with particular emphasis on HIV-associated dysplasia.  Bone marrow biopsy in aplastic anaemia.  Hypoplastic MDS/AML versus aplastic anaemia.  Influence of haematopoietic growth.  FAB-classification and clinical aspects of leukaemia.  Bone marrow features in acute leukemia.  Effect of leukaemia therapy on bone marrow histology.  Detection of minimal disease.  Differential diagnosis of chronic myeloproliferative disorders.  Evolution of chronic myeloproliferative disorders.  Bone marrow fibrosis and its patterns.  Myelodysplastic syndromes versus chronic myeloproliferative disorders.  Acute leukaemia and transient myeloproliferative disorder in Down syndrome.  Bone marrow involvement by B-cell lymphomas.  Bone marrow involvement by T-cell malignant lymphomas.  Reactive lymphoid aggregates in the bone marrow.  Potential of bone marrow biopsy/aspirate for classification, staging and monitoring of multiple myeloma.  Bone marrow involvement in plasma cell dyscrasias.  A clinician’s view.  Adhesion molecules in the pathophysiology of multiple myeloma.”




Constitutional Meeting, Utrecht, March 13

Jan van den Tweel, Kristin Henry, Demi Anagnostou, Konrad Muller-Hemerlink, Nina Hurwitz, Jacques Diebold, Bertha Frisch, Stephano Pileri.


Business meeting, Utrecht, 19-20 November

Included immunophenotyping of acute leukaemia. Nina Hurwitz and Francoise Delacretaz.




First discussion on Bone Marrow Study Group

Jan van den Tweel, Kristin Henry, Demi Anagnostou

EAHP meeting in Bologna, September 21-25.  Further discussions were held in Athens in December 1992


The Bone Marrow Study Group was conceived initially from an idea that emerged during a discussion between Demi Anagnostou and Jan van den Tweel, with the aim of exchanging views on bone marrow diagnostic problems and advances with others interested in the field.


An invitation letter, signed by Demi Anagnostou and Jan van den Tweel in Athens in January 1993 was addressed to Kristin Henry, Konrad Muller-Hemerlink, Nina Hurwitz, Jacques Diebold, Bertha Frisch and Stephano Pileri, who formed the first core of the Group.

The Group acquired official status for the first time during the business meeting in Basel , 2001, with election of a committee and president (Vito Franco, Hans Kreipe, Demi Anagnostou)



Next Meeting
XV EBMWG International Bone Marrow Course and Workshop
May 28-31, 2022
Lund, Sweden